Aggressive Breast Cancer Missed in Young Woman Due to Age Bias

Natasha May, then 27, experienced persistent exhaustion and a general feeling of being unwell in early 2020, symptoms she initially attributed to her job as a teacher. These symptoms, coupled with the discovery of a small, hard lump in her breast, were dismissed by her GP practice as likely hormonal and indicative of her young age. She was advised to wait several months before seeking further medical attention.

Weeks later, May received a diagnosis of triple-negative breast cancer, an aggressive form of the disease that is less responsive to common treatments and has a lower survival rate than other breast cancers. The five-year survival rate for triple-negative breast cancer is approximately 79 percent, compared to about 91 percent for breast cancer overall. This type of cancer is characterized by the absence of estrogen, progesterone, and HER2 receptors on the cancer cells.

May's experience highlights a critical issue in cancer detection: age bias. Despite her persistent concerns, she was told she was too young for breast cancer. Seeking a second opinion from a private GP, she was again met with skepticism due to her age and lack of family history. However, her conviction led to a referral to a breast clinic, where a mammogram and ultrasound confirmed her diagnosis after a biopsy.

"I was drastically younger than everybody else in the waiting room as well, which was quite daunting," May recalled. The diagnosis was stage one, grade three triple-negative breast cancer. She underwent 16 rounds of chemotherapy between June and August 2020, followed by a lumpectomy about six months after her diagnosis. Her treatment concluded with approximately ten rounds of radiotherapy in November 2020.

Organizations like Breast Cancer Now and Cancer Research UK recommend genetic counseling and testing for BRCA mutations for individuals diagnosed with triple-negative breast cancer, especially at a younger age, as faulty BRCA1 or BRCA2 genes can increase the risk. Robin Woolcock, chair of the UK Charity for Triple Negative Breast Cancer, emphasized that early detection and diagnosis are paramount for survival, particularly with this challenging form of cancer.

"All breast cancers are not the same and, because triple-negative breast cancer has no targeted treatments like other forms of the disease, survival rates are significantly worse," Woolcock stated. She also stressed the importance of breast self-checking for people of all ages, as triple-negative breast cancer is increasingly found in younger, pre-menopausal women who are not yet eligible for mammograms.

May gave birth to her daughter in 2024, an event that helped her process her past ordeal. "Having my daughter made me realize that if I hadn't had all this testing done, I wouldn't be here for her now," she said. She now advocates for others to be aware of their bodies, recognize changes, and advocate for themselves with healthcare providers, emphasizing that cancer has no age limit.

The NHS Breast Screening Programme in the UK typically invites women aged 50 to 53 for their first mammogram, with screenings every three years until age 71. However, women aged 40 to 49 can discuss their individual risk factors with a doctor, and private screening options are available.

Nikki Barraclough, chief executive of Prevent Breast Cancer, echoed the sentiment that early detection is vital, encouraging anyone with concerns to speak to their doctor and not hesitate to seek a second opinion. Cassie Kingswell, a clinical nurse specialist at Breast Cancer Now, advised younger women to be aware of breast cancer signs and symptoms, promoting the